CSBR vs CTVA · P/E 16, rev $56.9M vs P/E 42, rev $16.91B
Champions Oncology Inc (CSBR) versus Corteva Inc (CTVA) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Not investment advice. Open the CSBR and CTVA stock pages for the full models.
Not investment advice.